Biotech Stocks: Larger Caps are Favored until Momentum Returns…Update-2
Update-2….1016/26- ….Tech wreck continues with focus on AI infrastructure funding and capital. Need to see if broadening of market and new leadership emerges outside of tech. such as healthcare. Rebalancing can focus on large cap biopharma and energy. RISK off for SMID biotechs...
Biotech Bull Market Opportunities: Away from the madding crowd of compute?…Update-5
Update-5…10/9/26..3:17p EDT ALERT: Out of Nowhere comes a GREEN SCREEN in biotech!! IBB and XBI up 3%. Update-4 10/726 …Massive selling in ARKG yesterday took many genomics stocks down , now trading at about $50, down 7.58% over 5 days. Still In the bubble though up 73% YTD....
Biotech Stocks Slip into a Red Screen Day as the Market Hits the Snag of Geopolitical Tensions…Update-1
Update-1 Biotech and healthcare stocks look pretty good right now with many large caps still near their highs even Biogen (BIIB) at $228. The IBB at $209 has recovered from the mid-month sell-off. The XBI has lost momentum down 8% for the month, but should rally into the end of Q4, but we are...
Healthcare Sector Update after a Tough Week, Looking for Gains Ahead in Biotech…Update-1 Genomics stocks soar!
Update-1 SMID biotech movers today-Morgan Stanley Healthcare presentation– from our Focus Trading List: Many of these stocks are in the Cathy Wood managed ETF (ARKG). A green screen day in GENOMICS. We are long all of them. Adaptive Biotechnologies (ADPT) up 7.67% to $27. Cryoport (CYRX)...
Healthcare Stocks Hit A Speed Bump, but most TECH Stocks Roll On
Dow (DIA) is Down 2.3% month to date The XLV was down 2.52% to $167 reflecting the weighting of large cap biophrarma drugs in the ETF, the IBB was down 2.17% to the $207 level. The XLK was up only 0.32% but other tech sectors did better but volatile; SMH up 1.19%.,NVDA down 2%, AMD and DELL...
